Stereotaxis Inc.


in
Stereotaxis Inc. reported earnings results for the fourth quarter and year ended December 31, 2007. For the quarter, the company reported revenue was $10.3 million, a decrease of 27% from $14.0 million in revenue for the fourth quarter of 2006. The decline in revenue was principally due to the delay in European and FDA regulatory approvals for the Company's partnered magnetic irrigated catheter, which created a slowdown in backlog growth and revenues for its Niobe(TM) systems. Net loss was $12.2 million or $0.34 per basic and diluted share compared to $6.2 million or $0.18 per diluted share for the same period last year